| Dr Mark S O'brien, MD | |
|
11725 N Illinois St Ste 250, Carmel, IN 46032-3015 | |
| (317) 688-5300 | |
| (317) 688-5313 |
| Full Name | Dr Mark S O'brien |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 11725 N Illinois St Ste 250, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124129267 | NPI | - | NPPES |
| 200033390 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health North Hospital | Carmel, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Care Associates Inc | 5799755864 | 882 |
News Archive
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
How and when evolution generates diversity or gives form to proteins, living beings' functional building blocks, are essential questions that still surround the theory of evolution. In humans, the majority of genes have emerged via genetic duplication, a strategy in which a gene generates two identical copies that can evolve to generate different proteins.
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
A new study published by researchers at the UCLA School of Dentistry substantiates the effectiveness of measuring the microRNAs present in saliva to detect oral squamous cell carcinoma. Like hall monitors in an elementary school, microRNAs are the molecules produced by cells that simultaneously asses the behavior of multiple genes and control their activity.
› Verified 5 days ago
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
How and when evolution generates diversity or gives form to proteins, living beings' functional building blocks, are essential questions that still surround the theory of evolution. In humans, the majority of genes have emerged via genetic duplication, a strategy in which a gene generates two identical copies that can evolve to generate different proteins.
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
A new study published by researchers at the UCLA School of Dentistry substantiates the effectiveness of measuring the microRNAs present in saliva to detect oral squamous cell carcinoma. Like hall monitors in an elementary school, microRNAs are the molecules produced by cells that simultaneously asses the behavior of multiple genes and control their activity.
› Verified 5 days ago
| Entity Name | Pic Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942546890 PECOS PAC ID: 3476790239 Enrollment ID: O20130515000110 |
News Archive
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
How and when evolution generates diversity or gives form to proteins, living beings' functional building blocks, are essential questions that still surround the theory of evolution. In humans, the majority of genes have emerged via genetic duplication, a strategy in which a gene generates two identical copies that can evolve to generate different proteins.
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
A new study published by researchers at the UCLA School of Dentistry substantiates the effectiveness of measuring the microRNAs present in saliva to detect oral squamous cell carcinoma. Like hall monitors in an elementary school, microRNAs are the molecules produced by cells that simultaneously asses the behavior of multiple genes and control their activity.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark S O'brien, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Dr Mark S O'brien, MD 11725 N Illinois St Ste 250, Carmel, IN 46032-3015 Ph: (317) 688-5300 |
News Archive
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
How and when evolution generates diversity or gives form to proteins, living beings' functional building blocks, are essential questions that still surround the theory of evolution. In humans, the majority of genes have emerged via genetic duplication, a strategy in which a gene generates two identical copies that can evolve to generate different proteins.
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
A new study published by researchers at the UCLA School of Dentistry substantiates the effectiveness of measuring the microRNAs present in saliva to detect oral squamous cell carcinoma. Like hall monitors in an elementary school, microRNAs are the molecules produced by cells that simultaneously asses the behavior of multiple genes and control their activity.
› Verified 5 days ago
Amanda Houchens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12188b N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-705-4550 Fax: 317-705-4559 | |
Sanju J Daftari, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11911 N Meridian St, Suite 150, Carmel, IN 46032 Phone: 317-621-6701 Fax: 317-621-6707 | |
Rachel Land, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 12188b N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-705-4550 Fax: 317-705-4559 | |
Heather Rae Schumann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 Phone: 317-415-6900 | |
Robert D Habig, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15229 Westfield Blvd, Carmel, IN 46032 Phone: 317-867-1236 Fax: 317-896-1299 | |
Erica Dryden Leazenby, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13250 Hazel Dell Pkwy, Suite 104, Carmel, IN 46033 Phone: 317-415-6900 Fax: 317-415-6910 | |
Catherine E Broach, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 Phone: 317-415-6900 |